Name | Anti-TnC-A1 Antibody-Cytokine Fusion Protein, scFv (F16)-IL2 |
---|---|
Supplier | Creative Biolabs |
Catalog | ACFP-SH028 |
Host | Human |
Clone | F16 |
Species Reactivities | Human |
Description | This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-TnC-A1 scFv to IL2. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the TnC-A1 as well as the biological activity of IL2. This fusion of cytokine to antibody fragment scFv allows for a targeted delivery and improves efficacy and pharmacokinetics. This immunocytokine was designed for treating solid tumors. |
Gene | Tnc |
Supplier Page | Shop |